Position in CRMD
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,488,621
-$1,894,805 QoQ
Shares Held
366,513
-2.8% QoQ
Ownership
0.467%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. CRMD ranks #119 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in CRMD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,488,621 | 366,513 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,383,426 | 376,907 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,009,667 | 258,785 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,598,779 | 210,940 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $882,345 | 143,238 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,050,528 | 129,695 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $968,895 | 119,913 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $688,040 | 158,901 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $564,869 | 133,224 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $616,229 | 163,891 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $560,793 | 151,566 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $517,611 | 130,381 | Shares | Defined | 2023-08-03 | |
| 2022-12-31 | $101,347 | 24,016 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $68,139 | 24,078 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $96,793 | 24,078 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $689,837 | 125,883 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $567,069 | 124,631 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $571,563 | 122,917 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $786,916 | 114,711 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $947,710 | 94,866 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $550,338 | 91,267 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $580,814 | 92,193 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $322,693 | 89,887 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||